Skip to content

DAILYZ HEALTH NEWS

ALL ABOUT DAILYZ HEALTH NEWS

  • Home
  • Infectious Disease
  • Metabolic
  • Neurological
  • Nutrition
  • Public Health

DAILYZ HEALTH NEWS

ALL ABOUT DAILYZ HEALTH NEWS

  • Home
  • Infectious Disease
  • Metabolic
  • Neurological
  • Nutrition
  • Public Health
Measles cases top 5,000
Health

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

November 9, 2026 Evan Vega

CDC reports 5,182 measles cases in US, highest since 1991, with 8 deaths; 96% of cases among unvaccinated or unknown status.

Lp(a) reduction, neutral outcome
Health

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

November 8, 2026 Evan Vega
Infant bleeding episodes jump
Health

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

November 8, 2026 Evan Vega
Amivantamab approved for HNSCC
Health

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

November 7, 2026 Evan Vega
FDA approves Rybrevant Faspro
Health

FDA Approves Rybrevant Faspro for Advanced Head and Neck Cancer

November 7, 2026 Evan Vega
Measles cases top 5,000
Health

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

November 9, 2026 Evan Vega

CDC reports 5,182 measles cases in US, highest since 1991, with 8 deaths; 96% of cases among unvaccinated or unknown status.

Lp(a) reduction, neutral outcome
Health

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

November 8, 2026 Evan Vega
Infant bleeding episodes jump
Health

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

November 8, 2026 Evan Vega
Amivantamab approved for HNSCC
Health

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

November 7, 2026 Evan Vega
Measles cases top 5,000
Health

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

November 9, 2026 Evan Vega

CDC reports 5,182 measles cases in US, highest since 1991, with 8 deaths; 96% of cases among unvaccinated or unknown status.

Lp(a) reduction, neutral outcome
Health

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

November 8, 2026 Evan Vega
Infant bleeding episodes jump
Health

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

November 8, 2026 Evan Vega
Amivantamab approved for HNSCC
Health

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

November 7, 2026 Evan Vega
FDA approves Rybrevant Faspro
Health

FDA Approves Rybrevant Faspro for Advanced Head and Neck Cancer

November 7, 2026 Evan Vega
Measles cases top 5,000
Health

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

November 9, 2026 Evan Vega

CDC reports 5,182 measles cases in US, highest since 1991, with 8 deaths; 96% of cases among unvaccinated or unknown status.

Lp(a) reduction, neutral outcome
Health

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

November 8, 2026 Evan Vega
Infant bleeding episodes jump
Health

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

November 8, 2026 Evan Vega
Amivantamab approved for HNSCC
Health

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

November 7, 2026 Evan Vega
Measles cases top 5,000
Health

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

November 9, 2026 Evan Vega

CDC reports 5,182 measles cases in US, highest since 1991, with 8 deaths; 96% of cases among unvaccinated or unknown status.

Lp(a) reduction, neutral outcome
Health

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

November 8, 2026 Evan Vega
Infant bleeding episodes jump
Health

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

November 8, 2026 Evan Vega
Amivantamab approved for HNSCC
Health

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

November 7, 2026 Evan Vega
FDA approves Rybrevant Faspro
Health

FDA Approves Rybrevant Faspro for Advanced Head and Neck Cancer

November 7, 2026 Evan Vega
Glowing digital brain emerging from a laptop, symbolizing the MCP protocol and advanced AI integration.
Health
April 18, 2026 Evan Vega

MCP Protocol Is About to Change How You Use AI

Anthropic quietly released a specification that lets any AI tool access any data source through a single standard interface. Within months, the entire ecosystem adopted it. The biggest use case — pers

Read More
Enhanced Immune Signaling Tumor
Health
April 17, 2026 Evan Vega

Researchers Boost Cancer-Killing Immune Cells with Specific Signaling for Precise Tumor Attacks

Researchers engineered myeloid cells to deliver interleukin-12 to tumors, activating immune cells and reducing lung metastases in mice.

Read More
2025-2026 COVID Vaccine Efficacy
Health
April 17, 2026 Evan Vega

JAMA Analyzes Protection of 2025-2026 COVID Vaccines Against Latest SARS-CoV-2 Variants

JAMA published an analysis on the 2025-2026 COVID vaccines’ effectiveness against new Omicron subvariants LP.8.1 and JN.1 in the U.S.

Read More
Colorectal Screening Increase USA
Health
April 17, 2026 Evan Vega

Colorectal Cancer Screening Uptake Rises Among US Adults Aged 45-49, JAMA Study Evaluates Changes

Colorectal cancer screening among U.S. adults aged 45-49 rose to 34.5% in 2022 following updated screening guidelines.

Read More
Lebanon casualties Israeli attacks
Health
April 17, 2026 Evan Vega

Lebanon Health Ministry Reports 2,167 Killed in Israeli Attacks Since March 2

The Lebanon Health Ministry reported 2,167 deaths from Israeli attacks between March 2 and early April 2026 amid ongoing conflict.

Read More
Digital illustration of a human brain connected to a laptop, symbolizing AI memory and data processing challenges.
Health
April 16, 2026 Evan Vega

The AI Memory Problem Nobody’s Solving

Every AI conversation starts from zero. The tools to fix this have existed for years — vector databases, semantic embeddings, open protocols. But a billion-dollar industry keeps selling subscriptions

Read More
Targeted gum disease therapy
Health
April 16, 2026 Evan Vega

New Targeted Gum Disease Treatment Developed That Preserves Helpful Mouth Bacteria

Researchers developed targeted gum disease treatments that inhibit harmful bacteria while preserving beneficial oral microbes, announced in 2024.

Read More
Vitamin B1 Reactive Stabilization
Health
April 16, 2026 Evan Vega

Vitamin B1 Theory 67 Years Old Finally Proven Through Stabilization of Reactive Molecule

Researchers at UC Riverside confirmed vitamin B1 forms a stable carbene in water, proving a 67-year-old hypothesis by Ronald Breslow.

Read More
Tumors Suppress Immune Response
Health
April 15, 2026 Evan Vega

Aggressive Breast Cancer Research Reveals How Tumors Suppress Immune System

Researchers discovered how aggressive triple-negative breast cancer tumors suppress the immune system by hijacking checkpoints and increasing regulatory T cells.

Read More
Genetics Influences Lifespan More
Health
April 15, 2026 Evan Vega

Genetics Plays Larger Role in Lifespan Than Previously Believed, Weizmann Institute Study Shows

A 2026 Weizmann Institute study finds genetics influence 50-55% of human lifespan, doubling previous estimates by analyzing twin data.

Read More
  • ← Previous
  • Next →
Copyright © 2026 DAILYZ HEALTH NEWS. Powered by ColorMag and WordPress.